MedPath

criteria for Titration of atropine based on clinical symptoms of organophosphorus poisoning patients

Not Applicable
Conditions
Health Condition 1: T78- Adverse effects, not elsewhere classified
Registration Number
CTRI/2021/02/031201
Lead Sponsor
Ashwini
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients admitted with Organophosphorus poisoning in the intensive care unit of Kasturba hospital Manipal.

2.Organophosphorus poisoning patients those who are on treatment with injection Atropine infusion.

3.Organo phosphorus poisoned patients above 18 years and who are willing to participate in the study by giving informed consent.

Exclusion Criteria

1.Organophosphorus poisoning patients those who are not on treatment with injection atropine infusion

2.Organophosphorus poisoned Patients less than 18 years

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
measures: It includes Mortality,clinical symptoms, number of days of ICU,number of days of Hospitalization.Timepoint: measures: It includes Mortality, number of days in ICU, clinical symptoms, number of days Hospitalization.
Secondary Outcome Measures
NameTimeMethod
sefulness of parameters in titration of atropine and patient outcome in organophosphorus poisoningTimepoint: at baseline
© Copyright 2025. All Rights Reserved by MedPath